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One hundred four serogroup A meningococci in our collection, isolated in
Africa from 1988 to 1999, were characterized by multilocus sequence typing
(MLST). Our results and data from the Internet indicate that sequence type
5 (ST-5) strains were responsible for most of African outbreaks and spo-
radic cases during this period. In 1995, a new clone, characterized by ST-7
sequence, emerged and was responsible for severe outbreaks in Chad
(1998) and Sudan (1999). MLST and epidemiologic data indicate that ST-5
and ST-7 represent two virulent clones. These two STs, which belong to
subgroup III, differ only in the pgm locus: allele pgm3 is characteristic for
ST-5 and allele pgm19 for ST-7. Subgroup III strains were responsible for
two pandemics in the 1960s and 1980s. Our data show that the third sub-
group III pandemic has now reached Africa.
Multilocus enzyme electrophoresis (MLEE) has been the
reference method for global epidemiology of Neisseria menin-
gitidis. This method identified clusters of closely related
strains (for example, subgroup III for serogroup A N. menin-
gitidis and ET-5 complex for serogroup B  N. meningitidis)
and permitted monitoring of their clonal spread throughout
the world (1-3). This method, however, relies on the indirect
assignment of alleles based on the electrophoretic mobility of
enzymes. However, indistinguishable variants may be
encoded by very different sequences, and results obtained in
different laboratories may be difficult to compare. Rather
than comparing the electrophoretic mobilities of the enzymes
they encode, Maiden et al. adapted this method by identify-
ing alleles directly from the nucleotide sequences of internal
fragments of housekeeping genes (4). This new method,
called multilocus sequence typing (MLST), is based on the
sequencing of DNA fragments belonging to seven housekeep-
ing genes. MLST results are unambiguous and distinguish
more alleles per locus, allowing high-level discriminations
between isolates. The first data published by Maiden showed
good congruence between MLST and MLEE (4).
The aim of our study was to check MLST for the charac-
terization of 104 serogroup A N. meningitidis in our collec-
tion, isolated in 14 African countries from 1988 to 1999, to
determine the feasibility of the technique and which
sequence types were circulating in some African countries
during this period. 
Materials and Methods
Bacterial Strains
A total of 104 serogroup A N. meningitidis strains iso-
lated in 14 African countries from 1988 to 1999 and received
at the World Health Organization Collaborating Centre in
Marseilles were included in this study; 101 were isolated
from cerebrospinal fluid (CSF), 1 from blood culture of a
patient with meningococcal meningitis, and 2 from pharynx
(Table). For some outbreaks, we randomly chose three
strains for sequencing, if the pulsed-field gel electrophoresis
(PFGE) fingerprint patterns were identical (Chad 1988, Cen-
tral African Republic 1992, and Senegal 1998 outbreaks).
Since 1999, all meningococcal strains have been routinely
assayed by MLST. 
All these strains were stored at -80°C in brain heart
broth with 15% glycerol. The identification number for each
strain was preceded by Mrs for Marseilles. 
Bacterial Identification, Serogrouping, Typing, Subtyping
Bacterial identification was carried out by Gram stain-
ing, oxidase test, and tests for biochemical characteristics by
using a ready-for-use kit (Neisseria 4H Sanofi Pasteur, Paris,
France). N. meningitidis strains were serogrouped by agglu-
tination with sera manufactured in Institut de Médecine
Tropicale du Service de Santé des Armées (Marseilles). Sero-
types and subtypes were determined by using the mono-
clonal kit from the National Institute of Public Health and
the Environment (Bilthoven, the Netherlands) and the
whole-cell enzyme immunoassay technique described else-
where (5,6; Abdillahi, unpub. data). 
Whole chromosomal DNA was compared by PFGE of
macrorestriction fragments generated by endonuclease  Bgl
II (7). Agar plugs containing bacteria were treated by
lysozyme, Proteinase K, and then Pefabloc (Roche, Meylan,
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Table. Characteristics of 104 serogroup A meningococci isolated in Africa, from 1988 to 1999a
Yr. Country
No.
meningitis 
cases Type   Subtype
Allele no.
Sequence
type (ST)
No.  of 
isolates Serogroup abcZ adk aroE fumC gdh pdhC pgm
1988 Chad 7,867 3 A 4 P1.9 1 1 2 1 3 2 3 ST-5
1991 Djibouti 31 1 A 4 P1.9 1 1 2 1 3 2 3 ST-5
1992 Algeria 529 4 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Algeria 1 A 4 P1.10 1 3 1 1 1 1 3 ST-1
Burundi 2,739 4 A 4 P1.9 1 1 2 1 3 2 3 ST-5
CAR 1,226 3 A 4 P1.9 1 1 2 1 3 2 3 ST-5
1993 Cameroon 5,372 3 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Guinea- 
Bissau
3 A 4 P1.9 1 1 2 1 3 2 3 ST-5
1994 Burundi 42 1 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Cameroon 578 2 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Chad 948 1 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Zaire 3 A 4 P1.9 1 1 2 1 3 2 3 ST-5
1995 Algeria 1 A 4 P1.9 1 1 2 1 3 2 19 ST-7
Cameroon 2 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Burk. Faso 2,595 1 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Burk. Faso 1 A 4 P1.9 2 1 2 1 3 2 3 ST-580
Niger 43,203 4 A 4 P1.9 1 1 2 1 3 2 3 ST-5
1996 Burk. Faso 42,129 2 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Cameroon 178 3 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Chad 1,079 1 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Niger 16,145 3 A 4 P1.9 1 1 2 1 3 2 3 ST-5
1997 Burk.Faso 22,305 1 A 4 P1.9 2 1 2 1 3 2 3 ST-580
Cameroon 572 2 A 4 P1.9 1 1 2 1 3 2 19 ST-7
Chad 1,123 1 A 4 P1.9 1 1 2 1 3 2 19 ST-7
Mali 11,228 2 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Niger 4,910 6 A 4 P1.9 1 1 2 1 3 2 3 ST-5
1998 Cameroon 2,887 1 A 4 P1.9 1 1 2 1 3 2 19 ST-7
Chad 7,964 2 A 4 P1.9 1 1 2 1 3 2 19 ST-7
Côte
d’Ivoire 3 2 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Niger 2,328 4 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Senegal 2,709 3 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Zaire 1,991 2 A 4 P1.9 1 1 2 1 3 2 19 ST-7Research
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France). Plugs were incubated with 25 U of the endonuclease
Bgl II (Eurogentec, Seraing, Belgium) overnight at 37°C.
Electrophoresis was performed with a CHEF Mapper (Bio-
Rad Laboratories, Hercules, CA) in 0.5x Tris-borate-EDTA at
14°C, and a voltage of 4.5 V/cm was applied with a pulse-
time ramping from 30 seconds to 1 second over 22 hr. Then a
pulse of 0.1 to 1 second was applied for 2 hours and 30 min-
utes with a voltage of 6 V/cm. Fingerprint patterns were
analyzed by using Tenover criteria (8).
For MLST, the primers of the housekeeping genes abcZ
(putative ABC transporter),  adk  (adenylate kinase),  aroE
(shikimate dehydrogenase), gdh (glucose-6-phosphate dehy-
drogenase),  pdhC (pyruvate dehydrogenase subunit), and
pgm (phosphoglucomutase) were synthesized by our insti-
tute according to the sequences published by Maiden et al.
(4). A seventh locus, fumC (fumarase), was added. Primers
for amplification and sequencing of  fumC fragment were
synthesized from the sequences given on the MLST web site,
http://www.mlst.net. After DNA preparation and amplifica-
tion by polymerase chain reaction (PCR), each locus
sequence was analyzed on an ABI prism 310 Genetic Ana-
lyzer (Perkin-Elmer [PE] Applied Biosystems, Foster City,
CA) or ABI prism 373 DNA Sequencer (PE Applied Biosys-
tems). The sequence alignment was performed on the
Sequence Navigator software (PE Applied Biosystems). The
sequences were then compared with the different existing
alleles registered on the MLST web site.
Results 
Bacterial Identification, Grouping, Typing, Subtyping
All 104 strains were gram-negative diplococci, oxidase
positive, and catalase positive. They were classified as N.
meningitidis on the basis of growth characteristics on selec-
tive medium, acidification of glucose and maltose, and
gamma-glutamyl transferase activity (9). One hundred three
strains were serogroup A, type 4, and subtype P1.9
(A:4:P1.9), the same formula as strains belonging to sub-
group III. One strain isolated in Algeria in 1992 was
A:4:P1.10.
DNA fingerprint patterns generated with endonuclease
Bgl II  and analyzed by PFGE showed 103 closely related fin-
gerprint patterns. Two profiles could be identified. ST-5 was
the first pattern found in Africa and the most frequently iso-
lated from 1988 to 1996 (7). The second profile was the ST-7
pattern, attributable to strains isolated more recently in
Algeria, Cameroon, Sudan, Chad, and Niger. The two pat-
terns are closely related but have four band differences (Fig-
ure). Most strains analyzed by PFGE were indistinguishable
from ST-5 or ST-7. However, one strain (Mrs 99032) isolated
in Dakar (1999) from CSF, showed two band differences with
the outbreak pattern; and two strains (Mrs 95042, Mrs
97060), isolated in Burkina Faso in 1995 and 1997, showed
one band difference with the ST-5 pattern. Strains with the
ST-7 profile had almost the same patterns, but one strain
(Mrs 98118), isolated in Zaire in 1998, showed one band dif-
ference. One serogroup A:4:P1.10 meningococcus (Mrs
92060), isolated in 1992 in Algeria, had a totally different
profile; this strain was not related to the other 103 strains.
All strains isolated from outbreaks in Chad (1988), Central
African Republic (1992), and Senegal (1998) had identical
PFGE fingerprint patterns; we sequenced three strains ran-
domly chosen from these isolates (data not shown).
The MLST comparison between sequences and existing
alleles allowed us to assign our sequences allele numbers
(Table). On the MLST web site, the allele combination
assigned 100 of 104 strains to ST-5 or ST-7 because they
were identical to the consensus at seven loci. One strain
(Mrs 92060), isolated in Algeria in 1992, was assigned to ST-
1. Three strains had new STs: two strains (Mrs 95042, Mrs
97060), isolated in Burkina Faso in 1995 and 1997, were
abcZ2 and assigned to ST-580, and one strain (Mrs 99066),
isolated during the 1999 Senegal outbreak, was adk64 and
assigned to ST-581. 
Discussion
MLST technique was established in our laboratory at
the beginning of 1999. Since 2000, all meningococcal strains
we have received have been routinely characterized by this
method. The seven loci of the 104 serogroup A N. meningiti-
dis included in this study were characterized by their
sequences, and alleles were assigned directly at the MLST
web site (http://www.mlst.net), resulting in identification of
sequence types ST-1, ST-5, or ST-7 (Table). An e-mail with
sequence trace files was sent to the MLST web site to obtain
alleles and sequence types of three strains, subsequently
Table. Characteristics of 104 serogroup A meningococci isolated in Africa, from 1988 to 1999a (continued)
Yr. Country
No.
meningitis 
cases Type   Subtype
Allele no.
Sequence
type (ST)
No.  of 
isolates Serogroup abcZ adk aroE fumC gdh pdhC pgm
1999 Cameroon 2,272 2 A 4 P1.9 1 1 2 1 3 2 19 ST-7
Chad 2,540 2 A 4 P1.9 1 1 2 1 3 2 19 ST-7
Guinea- 
Bissau
2,836 2 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Niger 5,576 7 A 4 P1.9 1 1 2 1 3 2 19 ST-7
Senegal 4,939 6 A 4 P1.9 1 1 2 1 3 2 3 ST-5
Senegal 1 A 4 P1.9 1 64 2 1 3 2 3 ST-581
Sudan 33,313 11 A 4 P1.9 1 1 2 1 3 2 19 ST-7
aMultilocus sequence typing showed the clonal expansion of ST-5 and emergence of ST-7, which was identified for the first time in Algeria in 1995; in Cameroon
and Chad in 1997, 1998, and 1999; and in Zaire, Niger, and Sudan in 1999. Allele numbers and reference strains are registered at the MLST website (http://
www.mlst.net). CAR=Central African Republic.Research
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classified as ST-580 or ST-581 (Table). Except for ST-1, iden-
tified in strain Mrs 92061, ST-7, ST-580 and ST-581 differ
from ST-5 in only one locus, and these four related STs
belong to subgroup III. One hundred of 104 strains were
either ST-5 or ST-7. These two STs are closely related, differ-
ing only in pgm locus:  pgm3 is characteristic for ST-5 and
pgm19 for ST-7. These two alleles differ in sequence of 47 of
their base pairs, most likely because of recombination, fre-
quently seen in N. meningitidis (10,11). The surface epitopes
of strains analyzed in this study (e.g, serogroup, serotype,
and serosubtype) are identical in the strains of these two
STs. However, a four-band difference was observed in the
PFGE patterns, even though there is no BglII restriction site
in either locus pgm3 or locus pgm19. 
MLST and epidemiologic data indicate that strains of
ST-5 and ST-7 represent two virulent clones (Table). To date,
ST-5 strains have been isolated from several outbreaks:
Chad (1988), Central African Republic and Burundi (1992),
Cameroon (1993), Niger (1995, 1996), Burkina Faso (1996),
Mali (1997), Senegal (1998 and 1999), and Guinea-Bissau
(1999) (Table). ST-5 strains were also isolated from a carrier
returning from Saudi Arabia in 1987 (Centers for Disease
Control and Prevention, unpub. data), Gambia in 1997
(Greenwood, unpub. data), and Ghana in 1997 and 1998
(Popovic, Pluschke, unpub. data). In 1995, when ST-5 strains
were widespread, a new clone, characterized by ST-7,
emerged. The oldest ST-7 in our collection is from Algeria
(1995). ST-7 strains were isolated throughout the “meningi-
tis belt” (12): Chad (1997, 1998, and 1999), Cameroon (1997,
1998, and 1999), Zaire (1998), Niger (1999), and Sudan
(1999) (Table).
During the 11-year period 1988-1999, the ST-5 epidemic
wave reached all African countries in the meningitis belt. In
1995, the ST-7 clone appeared in Algeria. The origin and
emergence of the ST-7 clone might be explained by recombi-
nation events’ conferring selective advantages to ST-7.
Another possibility is that the homogenizing effect of a
sequential bottleneck might have selected at random a ST-7
clone among a limited number of different genotypes, result-
ing in a population uniform for the new variant (13,14).
Since their appearance in 1997, only strains of ST-7 have
been identified in Chad and Cameroon. Similarly, the 1999
Sudan outbreak was due to an ST-7 clone. Therefore, it
appears that ST-7 is a clonal replacement for ST-5 in African
countries. Prospective monitoring and analysis of the iso-
lates by MLST will be crucial for assessing the full signifi-
cance of our observations.
Serogroup A strains of subgroup III were associated
with the first pandemic that started in China in the mid-
1960s and subsequently spread to Russia, Scandinavia, and
Brazil. In the early 1980s, a second wave of meningococcal
disease caused by subgroup III clones began in China,
spread through Nepal and probably India, and then reached
Saudi Arabia in 1987 (2,3,15, 16). Given that this particular
clonal group had not been isolated in Africa before 1987, we
speculate that subgroup III, and more precisely the ST-5
clone, was introduced into Africa in 1987 by pilgrims return-
ing from Mecca (17-19). By 1988, epidemics of meningococcal
disease were recorded in Chad and Sudan, eventually reach-
ing most African countries (20; MLST web site). In 1995 and
1997, the ST-7 clone emerged in Africa and appears to be
responsible for a new wave of epidemics.
Achtman et al. showed that the third pandemic caused
by subgroup III began in China in 1993, causing large epi-
demics in Mongolia in 1994 and Moscow in 1996 (21). The
strain associated with this pandemic can be readily recog-
nized by the presence of the  pgm19 allele. Results of our
study suggest that this third pandemic has now reached
Africa.
Implications of the ST-7 clone’s replacing ST-5 can be
substantial. Chad and probably Sudan experienced epidem-
ics caused by ST-5 in 1988. Although ST-5 and ST-7 are
closely related clones, herd immunity due to the presence of
the ST-5 strains is now apparently surpassed since these two
countries had severe outbreaks caused by the ST-7 clone in
1998 and 1999.
Justified concern is raised now that the new pandemic of
subgroup III will spread to other countries of the meningitis
belt. It is important to alert those countries, particularly
Cameroon and Niger, where sporadic ST-7 strains are
already present.
Figure. Pulsed-field gel electrophoresis analysis of chromosomal
DNA (ethidium bromide staining) of 104 strains isolated in Africa.
DNA macrorestriction fragments were generated with BglII; 103 out
of 104 strains showed closely related profiles. ST-5 pattern was the
first pattern found in Africa and the most frequently isolated from
1988 to 1996. The second pattern was the ST-7 pattern, attributable
to strains isolated more recently in Algeria, Cameroon, Sudan,
Chad, and Niger. ST-7 pattern is closely related to ST-5 pattern but
shows four band differences (arrows 1,2,3,4). Mrs 99032, isolated in
Dakar in 1999 and belonging to ST-5, showed two band difference
with ST-5 pattern (arrows 3,5). Mrs 99066, isolated in Dakar (1999)
and belonging to ST 581, showed indistinguishable fingerprint with
ST5 pattern (not shown). Strains Mrs 95042 and Mrs 97060, isolated
in Burkina Faso in 1995 and in 1997, respectively, and belonging to
ST-580, showed one band difference with ST-5 pattern (arrow 6).
Lane a, pulsed-field gel electrophoresis marker I (Boehringer Mann-
heim Biochemicals, Indianapolis, IN).Research
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Among our 104 strains, 4 did not belong to ST-5 or ST-7
and were characterized by sequences ST-1, ST-580, and ST-
581. The ST-1 strain, belonging to subgroup I, was isolated in
Algeria in 1992. Subgroup I has been responsible for epidem-
ics and sporadic cases in Africa since 1961. Although it has
not been isolated for many years in the meningitis belt, it
was still the predominant clone in South Africa in 1996
(2,3,22). In addition to three strains of ST-5 isolated in
Burkina Faso in 1995 and 1996, two strains isolated in 1995
and 1997 were ST-580. This particular type is closely related
to ST-5, differing only at the abcZ locus. Isolation of only a
couple of strains of ST-580 substantially hampers specula-
tion that ST-580 is a genetic variant that could potentially
emerge. Finally, the third ST that differed from ST-5 was ST-
581, which had a new adk allele (Table). A strain of this type
was isolated from the CSF of a patient in Senegal in 1999.
However, this new clone will probably not emerge as a viru-
lent clone (i.e., to replace ST-5); indeed, it will probably be
lost in the future.
Although MLST makes standardization and interlab-
oratory comparison easier, the technique is time-consuming
and expensive. Some simplifications may be possible. For
example, 11 strains isolated during the 1999 Sudan out-
break showed the same PFGE fingerprint patterns as well as
identical ST. In this case,  sequencing only one strain would
have been sufficient. However, strain Mrs 99066 of ST-581,
isolated in Dakar in 1999, had a PFGE pattern identical to
that typically seen in the strains of the ST-5 pattern. With
few such exceptions, Bgl II PFGE analysis resulted in easy
differentiation of ST-5 and ST-7 strains. Their PFGE pat-
terns remained unchanged over several years and in strains
isolated in different countries. Although it is accepted that
PFGE is not appropriate for long-term comparison purposes,
it may discriminate ST-5 from ST-7 strains of N. meningitidis
serogroup A. Also, in epidemiologic investigations, differenti-
ation of  pgm3 from pgm19 in serogroup A strains recently
isolated in Africa may be useful for differentiating ST-5 and
ST-7. That could be accomplished by sequencing or by RFLP-
PCR of  pgm locus. However, the disadvantage of this
approach is that strains of ST-580 would be identified as
belonging to ST-5.
Since we established MLST in our laboratory in 1999, it
has allowed us to obtain reliable and portable data that
could be easily compared between laboratories without hav-
ing to exchange strains. MLST was initially developed for
studies of meningococcal population genetics. In this study,
MLST was used along with epidemiologic data to identify
two virulent clones characterized by ST-5 and ST-7. Strains
of the ST-5 were responsible for the second pandemic wave
that started in Africa in 1988, and the appearance of ST-7
strains may likely be responsible for the third one. In our
study, MLST has proven to be a reliable and useful tool for
molecular typing of N. meningitidis serogroup A and could
replace MLEE as the standard for molecular typing. MLST
may aid in identifying and monitoring the global spread of
virulent STs to allow rapid implementation of preventive
measures. 
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